Literature DB >> 20549699

The ARF tumor suppressor: structure, functions and status in cancer.

Peggy Ozenne1, Beatrice Eymin, Elisabeth Brambilla, Sylvie Gazzeri.   

Abstract

The INK4b-ARF-INK4a locus encodes two members of the INK4 family of cyclin-dependent kinase inhibitors, p15(INK4b) and p16(INK4a), and a completely unrelated protein called ARF. ARF is a nucleolar protein with unusual structure that exhibits tumor suppressive functions. There is growing evidence that ARF signaling is complex, and involves p53-dependent or -independent pathways aiming mainly at restraining abnormal cell growth and at maintaining genomic stability. As such, ARF is a critical component of tumor surveillance, and its expression is decreased in human tumors. In this review, we present the current knowledge on ARF regulation and major functions. The ARF status in human tumors is also briefly summarized.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549699     DOI: 10.1002/ijc.25511

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  81 in total

Review 1.  Patterns of Chromosomal Aberrations in Solid Tumors.

Authors:  Marian Grade; Michael J Difilippantonio; Jordi Camps
Journal:  Recent Results Cancer Res       Date:  2015

2.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

3.  Efficient introduction of specific TP53 mutations into mouse embryonic fibroblasts and embryonic stem cells.

Authors:  Quan-Xiang Wei; Franciscus van der Hoeven; Monica Hollstein; Adam F Odell
Journal:  Nat Protoc       Date:  2012-05-17       Impact factor: 13.491

4.  Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.

Authors:  Robert D Kendig; Fumitake Kai; Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Invest       Date:  2017-04-13       Impact factor: 2.176

5.  A conformational switch regulates the ubiquitin ligase HUWE1.

Authors:  Bodo Sander; Wenshan Xu; Martin Eilers; Nikita Popov; Sonja Lorenz
Journal:  Elife       Date:  2017-02-14       Impact factor: 8.140

Review 6.  A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.

Authors:  A R Lourenço; P J Coffer
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

7.  Chimeric negative regulation of p14ARF and TBX1 by a t(9;22) translocation associated with melanoma, deafness, and DNA repair deficiency.

Authors:  Xiaohui Tan; Sarah L Anzick; Sikandar G Khan; Takahiro Ueda; Gary Stone; John J Digiovanna; Deborah Tamura; Daniel Wattendorf; David Busch; Carmen C Brewer; Christopher Zalewski; John A Butman; Andrew J Griffith; Paul S Meltzer; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2013-06-03       Impact factor: 4.878

Review 8.  ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2016-01-11

9.  A p53/ARF-dependent anticancer barrier activates senescence and blocks tumorigenesis without impacting apoptosis.

Authors:  Vidya C Sinha; Lan Qin; Yi Li
Journal:  Mol Cancer Res       Date:  2014-09-24       Impact factor: 5.852

10.  Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways.

Authors:  Gernot Walter; Ralf Ruediger
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.